M.B. Assié

688 total citations
16 papers, 452 citations indexed

About

M.B. Assié is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, M.B. Assié has authored 16 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in M.B. Assié's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Receptor Mechanisms and Signaling (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). M.B. Assié is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Receptor Mechanisms and Signaling (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). M.B. Assié collaborates with scholars based in France, Sweden and Austria. M.B. Assié's co-authors include Wouter Koek, Elisabeth Carilla-Durand, Cristina Cosi, Adrian Newman‐Tancredi, Laurent Bardin, J.P. Tarayre, Françis C. Colpaert, Christiane Palmier, Bernard Vacher and Xiaohan Xu and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

M.B. Assié

16 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.B. Assié France 8 281 170 115 103 78 16 452
Elisabeth Carilla-Durand France 8 279 1.0× 185 1.1× 61 0.5× 81 0.8× 92 1.2× 10 456
Taiichiro Imanishi Japan 11 208 0.7× 168 1.0× 129 1.1× 47 0.5× 51 0.7× 17 422
Judit Laszy Hungary 10 275 1.0× 184 1.1× 69 0.6× 179 1.7× 36 0.5× 18 528
Helen Lamb United Kingdom 9 346 1.2× 298 1.8× 92 0.8× 65 0.6× 127 1.6× 9 574
Maggie D. Lalies United Kingdom 12 315 1.1× 247 1.5× 51 0.4× 38 0.4× 75 1.0× 17 492
Beatriz Braña Marcos Spain 11 238 0.8× 178 1.0× 136 1.2× 54 0.5× 118 1.5× 27 580
P. A. Baumann Switzerland 12 429 1.5× 269 1.6× 120 1.0× 140 1.4× 79 1.0× 18 642
J.‐L. PEGLION France 10 321 1.1× 258 1.5× 60 0.5× 58 0.6× 35 0.4× 17 627
Yaw Senyah United States 6 372 1.3× 199 1.2× 70 0.6× 65 0.6× 26 0.3× 7 460
Mark J. Benvenga United States 16 319 1.1× 194 1.1× 51 0.4× 67 0.7× 63 0.8× 28 552

Countries citing papers authored by M.B. Assié

Since Specialization
Citations

This map shows the geographic impact of M.B. Assié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B. Assié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B. Assié more than expected).

Fields of papers citing papers by M.B. Assié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.B. Assié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B. Assié. The network helps show where M.B. Assié may publish in the future.

Co-authorship network of co-authors of M.B. Assié

This figure shows the co-authorship network connecting the top 25 collaborators of M.B. Assié. A scholar is included among the top collaborators of M.B. Assié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.B. Assié. M.B. Assié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Auclair, Agnès L., J.-C. Martel, M.B. Assié, et al.. (2013). Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety. Neuropharmacology. 70. 338–347. 84 indexed citations
2.
Newman‐Tancredi, Adrian, J.-C. Martel, Jaroslava Buritova, et al.. (2008). P.2.d.013 F15599, a post-synaptic cortical preferential 5-HT1A agonist: I) functionally-selective signal transduction profile. European Neuropsychopharmacology. 18. S352–S353. 1 indexed citations
3.
Lladó-Pelfort, Laia, M.B. Assié, Pau Celada, Adrian Newman‐Tancredi, & Francesc Artigas. (2008). P.1.c.047 F15599, a post-synaptic cortical preferential 5-HT1A agonist: III) electrophysiology and microdialysis. European Neuropsychopharmacology. 18. S246–S246. 1 indexed citations
4.
Cosi, Cristina, et al.. (2006). Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. European Journal of Pharmacology. 535(1-3). 135–144. 70 indexed citations
5.
Assié, M.B., Laurent Bardin, Ronan Depoortère, Elisabeth Carilla-Durand, & Adrian Newman‐Tancredi. (2006). P.1.c.018 F15599, a highly selective serotonin 5-HT1A receptor agonist: in vivo profile in neurochemical and behavioural models of serotonergic activity. European Neuropsychopharmacology. 16. S233–S233. 8 indexed citations
6.
Newman‐Tancredi, Adrian, et al.. (2006). P.1.c.017 F15599, a highly selective serotonin 5-HT1A receptor agonist: in vitro affinity and efficacy profile at native rat and recombinant human 5-HT1A receptors. European Neuropsychopharmacology. 16. S232–S233. 1 indexed citations
7.
8.
9.
10.
Colpaert, Françis C., J.P. Tarayre, Wouter Koek, et al.. (2002). Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology. 43(6). 945–958. 115 indexed citations
11.
Koek, Wouter, M.B. Assié, Gerald Zernig, & Charles P. France. (2000). In vivo estimates of efficacy at 5-HT 1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats. Psychopharmacology. 149(4). 377–387. 21 indexed citations
12.
Koek, Wouter, Jean‐François Patoiseau, M.B. Assié, et al.. (1998). F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential. Journal of Pharmacology and Experimental Therapeutics. 287(1). 266–283. 59 indexed citations
13.
Assié, M.B. & Wouter Koek. (1996). (−)-Pindolol and (±)-Tertatolol Affect Rat Hippocampal 5-HT Levels Through Mechanisms Involving Not Only 5-HT1A, But Also 5-HT1B Receptors. Neuropharmacology. 35(2). 213–222. 33 indexed citations
14.
Assié, M.B., Marie Charvéron, Christiane Palmier, et al.. (1992). Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology. 31(2). 149–155. 38 indexed citations
15.
Assié, M.B., et al.. (1990). Repeated administration of milnacipran, a new antidepressant, has no effect on a functional β-adrenergic response in the rat brain. European Journal of Pharmacology. 183(3). 741–742. 5 indexed citations
16.
Assié, M.B., Marie Charvéron, & Mike Briley. (1988). In vivo [3H]ketanserin binding: effect of modifying synaptic serotonin levels. Neurochemistry International. 12(1). 85–89. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Carilla-Durand Breakdown of academic impact, for papers by Taiichiro Imanishi Breakdown of academic impact, for papers by Judit Laszy Breakdown of academic impact, for papers by Helen Lamb Breakdown of academic impact, for papers by Maggie D. Lalies Breakdown of academic impact, for papers by Beatriz Braña Marcos Breakdown of academic impact, for papers by P. A. Baumann Breakdown of academic impact, for papers by J.‐L. PEGLION Breakdown of academic impact, for papers by Yaw Senyah Breakdown of academic impact, for papers by Mark J. Benvenga
Rankless by CCL
2026